z-logo
open-access-imgOpen Access
Transcription Factor Nrf2 Protects the Brain From Damage Produced by Intracerebral Hemorrhage
Author(s) -
Xiurong Zhao,
Guanghua Sun,
Jie Zhang,
Roger Strong,
Pramod K. Dash,
Yuet Wai Kan,
James C. Grotta,
Jaroslaw Aronowski
Publication year - 2007
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.107.486506
Subject(s) - sulforaphane , medicine , intracerebral hemorrhage , oxidative stress , brain damage , cytotoxic t cell , myeloperoxidase , pharmacology , pathogenesis , keap1 , transcription factor , spontaneous intracerebral hemorrhage , immunology , inflammation , anesthesia , cancer research , biochemistry , biology , in vitro , gene , subarachnoid hemorrhage
Intracerebral hemorrhage (ICH) remains a major medical problem for which there is no effective treatment. Oxidative and cytotoxic damage plays an important role in ICH pathogenesis and may represent a target for treatment of ICH. Recent studies have suggested that nuclear factor-erythroid 2-related factor 2 (Nrf2), a pleiotropic transcription factor, may play a key role in protecting cells from cytotoxic/oxidative damage. This study evaluated the role of Nrf2 in protecting the brain from ICH-mediated damage.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom